Dysregulation in cerebral iron is reported to be associated with the progression of tau-mediated neurodegeneration, with elevations in iron in affected brain regions that correlate both with the progression of neurodegeneration and the formation of NFTs in tauopathies (Andrasi et al., 1995; Duce et al., 2010). This evidence concerns the gene MAPT and tauopathy.